Sol Gel Technologies Ltd (SLGL) Up 3.31% in Premarket Trading – InvestorsObserver

Sol Gel Technologies Ltd (SLGL) has gained Friday morning, with the stock climbing 3.31% in pre-market trading to 4.68. SLGL’s short-term technical score of 14 indicates that the stock has traded less bullishly over the last month than 86% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, SLGL ranks higher than 27% of stocks. Sol Gel Technologies Ltd has fallen 29.77% over the past month, closing at $6.20 on May 20. During this period of time, the stock fell as low as $5.03 and as high as $6.50. SLGL has an average analyst recommendation of Strong Buy. The company has an average price target of $17.00.

Overall Score - 35
SLGL has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on SLGL!

Sol Gel Technologies Ltd has a Long-Term Technical rank of 31. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 69% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, SLGL ranks better than 131% of stocks.

Important Dates for Investors in SLGL:

-Sol Gel Technologies Ltd is set to release earnings on 8/3/2022. Over the last 12 months, the company has reported EPS of $0.07. -We do not have a set dividend date for Sol Gel Technologies Ltd at this time. Click Here To Get The Full Report on Sol Gel Technologies Ltd (SLGL)
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy

source

Related Articles